Challenges for assessing replicability in preclinical cancer biology

Timothy M Errington1, Alexandria Denis1, Nicole Perfito2

  • 1Center for Open Science, Charlottesville, United States.

Elife
|December 7, 2021
PubMed
Summary

Replicating cancer biology research proved difficult due to insufficient data, poor experimental detail, and protocol modifications. These challenges highlight concerns about the credibility of preclinical findings.